Myriad acquires Germany-based diagnostic company
Salt Lake City-based Myriad Genetics has acquired Sividon Diagnostics, a breast cancer prognostic company based in Germany, for 35 million euro upfront with the potential for 15 million euro in additional performance-based milestones. The transaction closed on May 31. Salt Lake…